| European Case Law Identifier: | ECLI:EP:BA:2014:T252210.20140128 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 28 January 2014 | ||||||||
| Case number: | T 2522/10 | ||||||||
| Application number: | 02029008.6 | ||||||||
| IPC class: | C07K 1/18 C07K 16/32 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | A composition comprising anti-HER2 antibodies | ||||||||
| Applicant name: | Genentech, Inc. | ||||||||
| Opponent name: | Synthon B.V. | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Exclusion from file inspection (no) 'Confidentiality club' in EPO proceedings (no) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t102522eu2.html
Date retrieved: 17 May 2021